59 related articles for article (PubMed ID: 7919456)
21. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
Friche E; Jensen PB; Nissen NI
Cancer Chemother Pharmacol; 1992; 30(3):235-7. PubMed ID: 1628375
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
Lehne G; De Angelis P; den Boer M; Rugstad HE
Leukemia; 1999 May; 13(5):768-78. PubMed ID: 10374882
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
[TBL] [Abstract][Full Text] [Related]
25. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
[TBL] [Abstract][Full Text] [Related]
26. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
[TBL] [Abstract][Full Text] [Related]
27. Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells.
Gatouillat G; Odot J; Balasse E; Nicolau C; Tosi PF; Hickman DT; López-Deber MP; Madoulet C
Cancer Lett; 2007 Nov; 257(2):165-71. PubMed ID: 17517470
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
29. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
[TBL] [Abstract][Full Text] [Related]
30. FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro.
Pourtier-Manzanedo A; Boesch D; Loor F
Anticancer Drugs; 1991 Jun; 2(3):279-83. PubMed ID: 1724925
[TBL] [Abstract][Full Text] [Related]
31. Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.
Pourtier-Manzanedo A; Didier A; Loor F
Oncol Res; 1992; 4(11-12):473-80. PubMed ID: 1363723
[TBL] [Abstract][Full Text] [Related]
32. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.
Didier A; Loor F
Anticancer Drugs; 1996 Sep; 7(7):745-51. PubMed ID: 8949985
[TBL] [Abstract][Full Text] [Related]
33. Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833.
Liminga G; Nygren P; Larsson R
Exp Cell Res; 1994 Jun; 212(2):291-6. PubMed ID: 7910563
[TBL] [Abstract][Full Text] [Related]
34. Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.
Nooter K; Oostrum R; Jonker R; van Dekken H; Stokdijk W; van den Engh G
Cancer Chemother Pharmacol; 1989; 23(5):296-300. PubMed ID: 2706734
[TBL] [Abstract][Full Text] [Related]
35. Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
Schwabe K; Steinheider G; Lawen A; Traber R; Hildebrandt A
J Cancer Res Clin Oncol; 1995; 121(7):407-12. PubMed ID: 7635870
[TBL] [Abstract][Full Text] [Related]
36. The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions.
Tiberghien F; Wenandy T; Loor F
J Antibiot (Tokyo); 2000 May; 53(5):509-15. PubMed ID: 10908115
[TBL] [Abstract][Full Text] [Related]
37. Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.
Silverman JA; Hayes ML; Luft BJ; Joiner KA
Antimicrob Agents Chemother; 1997 Sep; 41(9):1859-66. PubMed ID: 9303374
[TBL] [Abstract][Full Text] [Related]
38. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia.
Keller RP; Altermatt HJ; Nooter K; Poschmann G; Laissue JA; Bollinger P; Hiestand PC
Int J Cancer; 1992 Feb; 50(4):593-7. PubMed ID: 1347037
[TBL] [Abstract][Full Text] [Related]
39. The activity of deoxyspergualin in multidrug-resistant cells.
Holmes JA; Twentyman PR
Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
[TBL] [Abstract][Full Text] [Related]
40. In vitro biosynthesis of [Thr2, Leu5, D-Hiv8, Leu10]cyclosporin, a cyclosporin-related immunosuppressive peptolide.
Lawen A; Traber R; Geyl D
Biomed Biochim Acta; 1991; 50(10-11):S260-3. PubMed ID: 1820056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
